Terns Pharmaceuticals, Inc. (TERN) Tops Q4 EPS by 6c

Terns Pharmaceuticals, Inc. (NASDAQ: TERN) reported Q4 EPS of ($0.24), $0.06 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Terns Pharmaceuticals, Inc. (TERN) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral
• SanDisk and Micron surge as Apple confirms memory price pass-through